Endothelium-derived nitric oxide (NO) is an important regulator of vascular function. NO is produced by endothelial NO synthase (eNOS), whose expression is downregulated by tumor necrosis factor (TNF)-␣ at the posttranscriptional level. To elucidate the molecular basis of TNF-␣-mediated eNOS mRNA instability, eNOS 3Ј untranslated region (3Ј-UTR) binding proteins were purified by RNA affinity chromatography from cytosolic fractions of TNF-␣-stimulated human umbilical vein endothelial cells (HUVECs). The formation of 3Ј-UTR ribonucleoprotein complexes, with molecular weight of 52 and 57 kDa, was increased by TNF-␣. Matrix-assisted laser desorption ionization time-of-flight mass spectrometric analysis of the 52-kDa protein identified 3 peptides that comprise the peptide sequence of translation elongation factor 1-␣ 1 (eEF1A1). In HUVECs, TNF-␣ rapidly increased eEF1A1 expression, which is maximal after 1 hour and persists for up to 48 hours. RNA gel mobility-shift and UV cross-linking assays indicated that recombinant glutathione S-transferase-eEF1A1 fusion protein specifically binds to a UC-rich sequence in the 3Ј-UTR of eNOS mRNA. In addition, the domain III of eEF1A1 mediates the binding of eNOS 3Ј-UTR in eEF1A1. Overexpression of eEF1A1 markedly attenuated the expression of eNOS and luciferase gene fused with eNOS 3Ј-UTR in both COS-7 cells and bovine aortic endothelial cells (BAECs). Furthermore, adenovirus-mediated overexpression of eEF1A1 increased eNOS mRNA instability, whereas knockdown of eEF1A1 substantially attenuated TNF-␣-induced destabilization of eNOS mRNA and downregulation of eNOS expression in HUVECs. These results indicate that eEF1A1 is a novel eNOS 3Ј-UTR binding protein that plays a critical role in mediating TNF-␣-induced decrease in eNOS mRNA stability. (Circ Res. 2008;103:591-597.) 
E ndothelial nitric oxide synthase (eNOS) is a key enzyme involved in the regulation of vascular function and abnormality of eNOS activity and/or expression has been shown to cause several vascular diseases. 1 Although eNOS was initially considered to be a constitutive enzyme, it was shown later that eNOS expression was regulated by a variety of exogenous stimuli. For instance, in cultured endothelial cells, cytokines, lipopolysaccharide, and oxidized LDLs have been shown to downregulate eNOS expression. 2, 3 In contrast, shear stress, estrogen, and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors have been demonstrated to upregulate eNOS expression. 4 -6 For many of these stimuli, modulation of eNOS mRNA stability plays an essential role in the regulation of eNOS expression. 7 However, the mechanism(s) responsible for the regulation of eNOS mRNA half-life remains to be determined.
One of the most potent inhibitory stimuli for eNOS expression in vascular endothelial cells is tumor necrosis factor (TNF)-␣. TNF-␣-mediated inhibition of eNOS expression, via a mechanism of destabilization of eNOS mRNA, has been shown to be associated with vascular dysfunction in several disease states, such as atherosclerosis, diabetes, and heart failure. 8, 9 It is becoming increasingly clear that the 3Ј-UTR of eNOS mRNA plays an important role in the posttranscriptional regulation of mRNA stability. 10 -12 For example, in BAECs, TNF-␣-induced eNOS mRNA destabilization is mediated, in part, by specific binding of a cytosolic 60-kDa protein to the 3Ј-UTR. 12 Furthermore, a 51-kDa protein was identified to bind to the eNOS 3Ј-UTR and regulate eNOS mRNA half-life during cell growth. 11 Similarly, in HUVECs, the binding of the 53-and 56-kDa proteins to the eNOS 3Ј-UTR has also been implicated in the modulation of mRNA stability by TNF-␣. 13 However, the identity of eNOS mRNA 3Ј-UTR binding proteins and precise mechanism by which these proteins regulate eNOS mRNA stability remain to be determined.
To identify the cytosolic proteins that could be important in regulating eNOS mRNA stability, we used a mass spectrometry (MS)-protein-sequencing approach to identify proteins that copurify with eNOS 3Ј-UTR from a cytosolic fraction of TNF-␣-stimulated HUVECs. From these studies, we found that the ribosomal protein translation elongation factor eEF1A1 (elongation factor 1-␣ 1), an actin binding protein, interacts with eNOS 3Ј-UTR and modulates eNOS mRNA stability in response to TNF-␣.
Materials and Methods
An expanded Materials and Methods section is available in the online data supplement at http://circres.ahajournal.org.
Briefly, HUVECs were routinely cultured and treated with TNF-␣ (20 ng/mL) for 24 hours. eNOS 3Ј-UTR binding proteins were purified by using RNA affinity chromatography and identified by matrix-assisted laser desorption ionization time-of-flight MS (MALDI-TOF-MS). The interaction of eEF1A1 with eNOS 3Ј-UTR was determined by RNA electrophoretic mobility-shift assay (R-EMSA) and UV cross-linking assay. Western blotting and Northern Blotting were performed following standard protocols. Adenovirus harboring Flag-tagged eEF1A1 was made using AdMax (Microbix). Gene-specific small interfering (si)RNA was transfected with Gene Silencer transfecting agent. Luciferase activity was determined using the Dual Luciferase Assay System (Promega).
Results

Identification of eEF1A1 As an eNOS 3-UTR Binding Protein
Previous studies indicated that TNF-␣ decreases the eNOS protein expression through destabilization of eNOS mRNA by cytosolic proteins, which bind to the 3Ј-UTR of eNOS mRNA. 10, [12] [13] [14] To identify these proteins, eNOS 3Ј-UTR binding proteins were purified from a cytosolic fraction of TNF-␣-unstimulated and -stimulated HUVECs, using RNA affinity chromatography via biotinylated transcripts coupled to streptavidin-agarose. The binding of 2 bands, at 57 and 52 kDa, to eNOS 3Ј-UTR was significantly upregulated in TNF-␣-stimulated HUVECs ( Figure 1A ). MALDI-TOF-MS analysis of the 52-kDa band identified 3 peptides (YYVTI-IDAPGHR, EHALLAYTLGVK, VETGVLKPGMVVT-FAPVNVTTEVK) that correspond to peptides deduced from translation eEF1A1. The identity of the 57-kDa protein remains to be characterized.
To determine whether eEF1A1 interacts with eNOS 3Ј-UTR, electrophoretic mobility shift assay (EMSA), with in vitro-translated eNOS 3Ј-UTR was used to further investigate the binding of eEF1A1 to the eNOS 3Ј-UTR. Glutathione S-transferase (GST)-eEF1A1, but not GST, shifted the radiolabeled eNOS 3Ј-UTR probe, whereas preincubation with cold eNOS 3Ј-UTR oligonucleotide completely eliminated this band shift ( Figure 1B) . EMSA, performed on cytosolic extracts from HUVECs transduced with adenovirus harboring eEF1A1 (AdeEF1A1), also demonstrated a ribonucleoprotein (RNP) complex formation, which was retarded by anti-eEF1A antibody ( Figure 1C ), providing further evidence of specificity of complex formation between eNOS 3Ј-UTR with eEF1A1 in HUVECs. In addition, eEF1A1-eNOS 3Ј-UTR interaction was assayed by UV cross-linking experiments. Complex formation between recombinant GST-eEF1A1 protein and the whole 3Ј-UTR transcript was observed, whereas the binding activity was not observed with the GST protein alone and was completely competed by excessive cold eNOS 3Ј-UTR transcript ( Figure 1D ). Furthermore, immunoprecipitation, followed by RT-PCR assays, also demonstrated the specific interaction of eEF1A and Identification and characterization of eNOS 3Ј-UTR binding proteins. A, eNOS 3Ј-UTR binding proteins were purified by RNA affinity chromatography from a cytosolic fraction of unstimulated and stimulated HUVECs with 20 ng/mL TNF-␣ for 24 hours. After extensive washing, proteins bound to the biotinylated eNOS 3Ј-UTR coupled to streptavidin-agarose beads were eluted with SDS-PAGE sample buffer, electrophoretically separated by 12% SDS-PAGE, and Coomassie-stained. The target protein bands at 57 and 52 kDa were digested with trypsin followed by MALDI-TOF-MS analysis. B, R-EMSA was performed by incubating the radiolabeled eNOS 3Ј-UTR with increasing concentrations of GST-eEF1A1 (1 and 5 g) and a fixed concentration of GST (5 g). Competition with specific competitor (50 molar excess) corresponding to unlabeled eNOS 3Ј-UTR transcript was also performed in the presence of 5 g of GST-eEF1A1. C, EMSA was performed by incubating the radiolabeled eNOS 3Ј-UTR with 30 g of cytosolic extracts from HUVECs transduced with AdeEF1A1 for 48 hours in the presence and absence of anti-eEF1A antibody. D, UV cross-linking was performed by incubating the radiolabeled eNOS 3Ј-UTR with increasing concentrations of GST-eEF1A1 (1 and 5 g) and a fixed concentration of GST (5 g). Competition with specific competitor (50 molar excess) corresponding to unlabeled eNOS 3Ј-UTR transcript was also performed in the presence of 5 g of GST-eEF1A1. E, Immunoprecipitation, followed by RT-PCR assays, showing interaction of eEF1A and eNOS mRNA 3Ј-UTR in HUVECs treated with or without TNF-␣ (20 ng/mL) for 1 hour.
eNOS mRNA 3Ј-UTR in both TNF-␣-unstimulated and -stimulated HUVECs. However, TNF-␣ stimulation markedly increased the levels of eNOS mRNA associated with eEF1A ( Figure 1E ).
Identification of the eEF1A-Binding Site in Human eNOS 3-UTR
Based on the human eNOS mRNA sequence deposited in the GenBank database (accession no NM_000603), eNOS 3Ј-UTR is 418-nt long (3906 to 4323). To localize the eEF1A1binding site within the eNOS 3Ј-UTR, a series of riboprobes corresponding to eNOS 3Ј-UTR deletion mutants were generated ( Figure 2A ) and used in UV cross-linking experiments. GST-eEF1A displayed a binding activity to riboprobes corresponding to 3906 to 4044 (139 nt), 3906 to 4155 (250 nt), 3906 to 4187 (272 nt), 3906 to 4243 (338 nt), 3979 to 4323 (345 nt), and full-length 3ЈUTR (418 nt) of eNOS mRNA, but not to the fragments of 3906 to 3978 (73 nt) and 4045 to 4325 (279 nt) of eNOS mRNA 3Ј-UTR ( Figure 2B ). Together, these results suggested that the eEF1A1-binding site is located in the region between 3979 to 4044 (66 nt), a UC-rich sequence in the 3Ј-UTR of eNOS mRNA (5Ј-GCCCCGCUCCUCCCC-UCUUGAGGUGGUGCCUUCUCACAUCUGUCCAGAGG-CUGCAAGGAUUCAGCAUUA-3Ј).
Identification of the eNOS 3-UTR Binding Site in eEF1A1
eEF1A is a highly conserved protein in eukaryotic cells, with 3 functional domains: namely, domain I, domain II, and domain III ( Figure 3A ). 15 Domain I and domain II have been shown to interact with GDP/GTP and aminoacyl-tRNA, respectively, whereas domain III interacts with actin and is responsible for the noncanonical functions of eEF1A in actin binding and bundling. 15, 16 To localize the site(s) essential for eNOS 3Ј-UTR binding in eEF1A1, we performed UV crosslinking assays by using bacterially expressed GST fusing proteins ( Figure 3B ). eNOS 3Ј-UTR strongly interacted with GST fusion proteins bearing the full length of eEF1A1 and eEF1A1 domain III, but not with domain I and domain II of eEF1A1 ( Figure 3C ). These results suggest that domain III of eEF1A1 is responsible for the eNOS 3Ј-UTR binding in eEF1A1.
Overexpression of eEF1A1 Decreases eNOS mRNA Stability and Inhibits eNOS Expression
The interaction of eEF1A1 with the eNOS mRNA 3Ј-UTR prompted us to investigate whether eEF1A1 affects eNOS expression through regulating eNOS mRNA stability. To this end, Myc-tagged eEF1A1 cDNA, together with eNOS cDNA containing its 3Ј-UTR, were cotransfected into Cos-7 cells, and the expression of eNOS was determined by Western blotting analysis. In a dose-dependent manner, cotransfection of eEF1A1 markedly inhibited eNOS expression in cotransfected Cos-7 cells ( Figure 4A ). In contrast, overexpression eEF1A1 had no effect on eNOS expression, when cotransfected with eNOS cDNA without its 3Ј-UTR sequence (data not shown). These results suggest that the binding of eEF1A1 to eNOS 3Ј-UTR may be functionally important for the regulation of eNOS expression.
To further determine whether the inhibitory effect of eEF1A1 on eNOS expression in intact cells results from its binding to the 3Ј-UTR, we performed luciferase analyses. We generated reporter vector with the eNOS 3Ј-UTR cloned behind the firefly luciferase reporter gene. The luciferase 
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reporter construct together with eEF1A1 expression vector or empty vector were transiently transfected into both Cos-7 cells and BAECs. In a concentration-dependent manner, overexpression of eEF1A1 decreased luciferase activity in both Cos-7 cells and BAECs ( Figure 4B and 4C). Together, these findings strongly suggest that the effect of eEF1A1 on eNOS mRNA is mediated by its binding to the eNOS 3Ј-UTR sequence.
Overexpression of eEF1A1 Mimics Destabilization of eNOS mRNA by TNF-␣ in HUVECs
Because the binding of eEF1A1 to the eNOS 3Ј-UTR was significantly increased by TNF-␣ treatment in HUVECs ( Figure 1A) , we sought to determine the role of eEF1A1 in TNF-␣ induced destabilization of eNOS mRNA. In a timedependent manner, treatment of HUVECs with TNF-␣ (20 ng/mL) rapidly increased eEF1A expression, which is maximal after 1 hour and persists for up to 48 hours ( Figure 5A ).
To determine whether overexpression of eEF1A1 can mimic the inhibitory effect of TNF-␣ on eNOS expression, preconfluent HUVECs were infected with AdeEF1A1 for 48 hours. The eNOS expression was then determined by Western blotting analysis. Indeed, overexpression of eEF1A1 markedly reduced eNOS protein expression by approximately 60% in HUVECs, compared to that observed with TNF-␣ treatment (ie, 75% reduction) ( Figure 5B ). The posttranscriptional regulation of eNOS mRNA by eEF1A1 was determined in the presence of the transcriptional inhibitor 5,6-dichloro-1-␤-D-ribofuranosylbenzimidazole (DRB) (20 g/mL). HUVECs were transduced with either AdeEF1A1 or AdLacZ for 48 hour. DRB was then added to stop transcription, and total RNAs were prepared 0 to 24 hours thereafter. Relative eNOS mRNA amounts were performed by Northern blotting analysis. Overexpression of eEF1A1 in HUVECs decreased the half-life of eNOS mRNA from 29Ϯ3 to 10Ϯ2 hours (PϽ0.05, nϭ5) ( Figure 5C and 5D ). Together, these results suggest that eEF1A1 is involved in the posttranscriptional regulation of eNOS mRNA stability.
eEF1A1 Knockdown Prevents Destabilization of eNOS mRNA by TNF-␣
To further substantiate the functional significance of eEF1A1 in the regulation of eNOS mRNA stability, we performed loss-of-function studies, using the RNA interference technique. Transfection of eEF1A1 siRNA substantially inhibited eEF1A1 expression by approximately 78% (Figure 6A ). Analysis of the half-life of eNOS mRNA in these cells showed that TNF-␣-induced destabilization of eNOS mRNA was clearly attenuated by eEF1A1 knockdown, as demonstrated in Figure 6B . Compared with control siRNA (CTLsiRNA), eEF1A-specific siRNA (eEFsiRNA) modestly prolonged the half-life of eNOS mRNA under basal conditions. In HUVECs transfected with control siRNA, TNF-␣ (20 ng/mL) shortened the half-life of eNOS mRNA from 32Ϯ3 to 8Ϯ2 hours (PϽ0.05, nϭ5). In contrast, knockdown of eEF1A1 by eEFsiRNA substantially blocked the decrease in eNOS mRNA half-life by TNF-␣ treatment. (8Ϯ2 to 19Ϯ2 hours, PϽ0.05, nϭ5). To determine whether the modulation of eNOS mRNA half-life by eEFsiRNA corresponds to eNOS mRNA expression, we transfected HUVECs with control or eEF1A1 siRNA before stimulation with TNF-␣ and measured the protein levels of eEF1A1 and eNOS. eEF1A1 siRNA substantially prevented TNF-␣-induced upregulation of eEF1A1 and subsequent downregulation of eNOS protein expression in HUVECs ( Figure 6C) . These results indicate that the regulation of eNOS mRNA stability and expression by TNF-␣ is specifically mediated, in part, by eEF1A1.
Discussion
The regulation of eNOS occurs at multiple levels, including gene transcription, posttranscriptional, and posttranslational mechanisms and protein-protein interactions. In response to a variety of stimuli, including cytokines, lipopolysaccharide, and oxidized LDLs, the modulation of eNOS mRNA stability plays an important role in the regulation of eNOS expression. 7 Previous studies suggest that the binding of cytosolic proteins to the cis-acting sequences within eNOS mRNA 3Ј-UTR was involved in the regulation of eNOS mRNA stability. 10 -13 However, the identity and function of these eNOS mRNA 3Ј-UTR binding proteins remain to be determined. In the present study, using RNA affinity chromatography to identify trans-acting factors that might regulate eNOS mRNA, we, for the first time, identified eEF1A1 as a cytosolic protein that binds to the eNOS 3Ј-UTR in HUVECs in response to TNF-␣ stimulation. The interaction of eEF1A1 with eNOS 3Ј-UTR was confirmed by EMSA and UV cross-linking assays. Furthermore, adenovirus-mediated overexpression of eEF1A1 and siRNA-specific knockdown led to alterations in eNOS mRNA half-life that were consistent with eEF1A1 being part of destabilization mechanism for eNOS mRNA. These results suggest that eEF1A1 may be an important regulator of vascular function through its effects on eNOS expression. eEF1A is an abundant and highly conserved protein in eukaryotic cells and is among the most extensively characterized proteins of the translational machinery. 17, 18 Two eEF1A isoforms, including eEF1A1 and eEF1A2, exist in humans, and these 2 proteins share 92% similarity. 19 Because of its role in protein translation, eEF1A possesses a strong RNA-binding activity. The canonical role of eEF1A during protein synthesis is to bind and transport aminoacyl-tRNA to the A site of the ribosome during translation in a GTPdependent mechanism. 20 During its normal cell functions, eEF1A interacts specifically with the other elongation complex proteins, tRNAs, and rRNA. Interestingly, eEF1A has been recently shown to bind to the 3-ЈUTR regions of several viruses, including tobacco mosaic virus, turnip yellow mosaic virus, dengue 4 virus, and West Nile virus, and these RNA protein interactions may play important roles in virus growth or viral RNA synthesis. [21] [22] [23] [24] At present, little is known about the function of eEF1A1 in vascular endothelial cells, besides its role in the translation. Our findings indicate that eEF1A1 is a novel eNOS 3Ј-UTR binding protein that mediates TNF-␣-induced destabilization of eNOS mRNA in HUVECs. Whether eEF1A2 interacts with eNOS 3Ј-UTR requires further investigation. The mechanism by which eEF1A1 destabilizes eNOS mRNA remains elusive. Recent studies suggest that the anchoring of mRNAs to the actin cytoskeleton and their colocalization with ribosomes and RNA-binding protein complexes are necessary for their stability and translational expression. 25, 26 Importantly, the role of the endothelial actin cytoskeleton in the posttranscriptional stabilization of eNOS mRNA has been described, 27, 28 Hypoxia, oxidized LDL, and cytokines such as TNF-␣ have been shown to decrease eNOS expression by reducing eNOS mRNA stability. 2,13,29 -31 In contrast, inhibition of Rho and actin cytoskeletal inhibitors have been shown to prolong eNOS mRNA half-life and prevent the downregulation of eNOS by oxidized LDL and TNF-␣ under hypoxic conditions. 27, 30, [32] [33] [34] Moreover, the interaction of actin with eNOS 3Ј-UTR has been shown to play an essential role in the posttranscriptional regulation of eNOS during cell growth. 28 These studies highlight the importance of actin and/or actin-binding proteins in the regulation of eNOS mRNA stability. Interestingly, beyond its conventional function in translation, eEF1A has been shown to play a key role in regulating cytoskeleton organization. 16, 35 The association of eEF1A with the cytoskeleton has been well established across species from yeast to mammals. 16, [35] [36] [37] It has been suggested that Ͼ60% of eEF1A in cells is predicted to be associated with the actin cytoskeleton. 38 Because eEF1A has been shown to cross-link actin filaments with a unique bonding rule that excludes other proteins that cross-link F-actin, 39 the resulting actin structure could be the scaffold for the transport and/or anchorage of mRNA. 40 The binding of eEF1A to actin is now regarded as a function that may link 2 distinct cellular processes, cytoskeletal organization and gene expression. 15 Thus, an intriguing possibility is that the association of eEF1A1 with eNOS mRNA 3Ј-UTR may affect eNOS mRNA stability by regulating the cytoskeletal-mediated eNOS mRNA transport, localization, and translation. In this regard, it would be interesting to investigate whether the dominant negative mutants of eEF1A1, such as domain III of eEF1A1, which has been shown to inhibit the interaction of eEF1A1 with F-actin, 15 could attenuate TNF-␣-induced destabilization of eNOS mRNA.
Using RNA affinity chromatography with a riboprobe encoding the entire human eNOS 3Ј-UTR as a matrix, we showed that the formation of 2 RNPs, with molecular masses of 52 and 57 kDa, was upregulated by TNF-␣. In this regard, our finding are consistent with a previous notion showing that the formation of the 53-and 56-kDa RNPs was upregulated in UV cross-linking assays of the human eNOS 3Ј-UTR with protein extracts from HUVECs treated with TNF-␣. 13 However, the identity of the 53 and 56-kDa factors was unknown. In this study, we have identified the 52-kDa protein as eEF1A1 by MS analysis. Because the expression of eEF1A was rapidly induced by TNF-␣, the changes in eEF1A binding to eNOS 3Ј-UTR may be attributed to the relative abundance of eEF1A in endothelial cells. However, at this point, we cannot exclude the possibility that the potential changes in the binding affinity, attributable to posttransla-tional modification, may also contribute to the increased binding of eEF1A to eNOS mRNA by TNF-␣ stimulation. Indeed, eEF1A has been shown to undergo phosphorylation and methylation. 18, 41 Interestingly, Rho kinase has been shown to phosphorylate eEF1A1 and regulate its binding to F-actin. 42 Because TNF-␣ has been shown to activate Rho kinase in vascular endothelial cells, [43] [44] [45] it remains to be determined whether Rho kinase mediated phosphorylation of eEF1A1 affects its interaction with eNOS 3Ј-UTR, thereby modulating the eNOS mRNA stability by TNF-␣.
In summary, our study provides the first evidence to our knowledge that eEF1A1 is a novel cytosolic protein that binds to the 3Ј-UTR sequence of eNOS mRNA. This interaction is specific and leads to a reduction in eNOS mRNA stability and eNOS mRNA expression. Further studies, however, are required to determine the pathophysiological role of eEF1A1 in vascular disease. Nevertheless, because eEF1A1 also functions as an actin binding protein, these results provide a paradigm that links the control of the endothelial actin cytoskeleton to the regulation of gene expression and suggest a therapeutic target that could improve endothelial function.
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Materials and Methods
Cell Culture
HUVECs were purchased from Clonetics and cultured in medium199 (M-199; BioWhittaker) containing endothelial cell growth supplement, 10% fetal bovine serum, and antibiotics (100 U/mL penicillin, 100 µg/mL streptomycin, and 20 µg/mL neomycin). Cos-7 and Bovine aortic endothelial cells (BAECs) were cultured in DMEM supplemented with 10% fetal bovine serum and antibiotics (100 U/mL penicillin, 100 µg/mL streptomycin).
Purification and Identification of eNOS mRNA 3'-UTR Binding Protein(s)
Cytosolic protein was extracted from confluent unstimulated HUVECs and HUVECs stimulated with TNF-α for 24 hr as described 1 
RNA Electrophoretic Mobility Shift Assay (R-EMSA)
The 3'-UTR RNA of human eNOS were transcribed in vitro from 1µg of linearized plasmid using T7 RNA polymerase and labeled internally with 50μCi[ 32 P]-UTP according to the manufacture's instructions(Ambion). R-EMSA assays were performed essentially as described previously 3 . Briefly, radiolabeled riboprobes (10 5 cpm) were incubated with 1-5µg protein or 30 μg cytosolic extracts in the binding buffer containing (in mmol/L): HEPES 10 (pH 7.4), MgCl 2 5, KCl 100, and DTT 1; 5% glycerol; 20U RNasin (Ambion), and 50ng/μL yeast tRNA (Ambion) for 30 minutes at room temperature. RNase T1 (25 U) was then added and the reaction mixtures were incubated for 10 min at 30 ℃. For competition assay, 50-fold excess of cold nonradiolabeled probes were incubated with GST-eEF1A1 for 10 minutes before the addition of radiolabeled probes. For supershift assay, goat polyclonal antibody to eEF1A (Santa Cruz) was used. The experimental protocol was identical to EMSA except 4µg anti-eEF1A antibody was incubated with cytosolic extracts on ice for one hour before the addition of radiolabeled probes.
The RNA-protein complexes were separated by electrophoresis in a 4.5% (W/V) nondenaturing polyacrylamide gel containing 1×TBE. The gel was running in 1×TBE for 2h at 30mA before exposure to x-ray film at -80℃ with an intensifying screen.
UV Cross-linking Assay
The 3'-UTR and its deletion mutants RNA probe of human eNOS were prepared as described for the R-EMSA assays. Radiolabeled riboprobes (1X10 6 cpm) were incubated with 4μg GST or GST-eEF1A1 fusion proteins for 20 min at 37℃ in 30μl binding buffer. Subsequently, the reaction mixture was irradiated for 20 min in a UV-cross-linker model 2400 (Stratagene).
RNase T1 was then added to the reaction mixture for 30min at 30℃. The samples were boiled for 3 minutes in Laemmli buffer and separated by electrophoresis on a 10% SDSpolyacrylamide gel. The gel was dried and exposed to x-ray film at -80℃ with an intensifying screen.
Immunoprecipitation/Reverse Transcription-PCR Assay
TNF-α unstimulated and stimulated HUVECs were washed twice with cold phosphate-buffered saline, and then lysed for 30 min on ice in 1.5ml of lysis buffer (20mM Tris pH7.4, 0.1% Triton X-100, 2mM EDTA, 25mM NaCl, 10% Glycerol, protein inhibitors, and 100 units of RNase OUT (Invitrogen). The pre-cleared lysates were incubated 2h at 4℃ with 3 μg anti-eEF1A monoclonal antibody (Santa Cruz) and a control mouse IgG, followed by incubation with protein G-Sepharose saturated first with yeast tRNA (100μg/ml). The immunocomplexes were washed four times with 1ml lysis buffer, and the total RNA was purified with Trizol Reagent (Invitrogen) as described. RT-PCR was carried out with SuperScript Ⅲone-step RT-PCR kit (Invitrogen) with the following primers (primer 1: 5' TTT AAA GAA GTG GCC AAC GCC GTG 3'; primer 2: 5' AGC GGA TTG TAG CCT GGA ACA TCT 3'). PCR products were analyzed on a 1.5 % agarose gel and visualized by ethidium bromide staining. Each experimental reaction was performed in triplicate.
Construction of adenovirus
Adenovirus harboring eEF1A1 was made using AdMax (Microbix). Briefly, pBHGlox E1,3Cre, including the E1 adenoviral genome, was cotransfected with the pDC shuttle vector containing the gene of interest into Ad293 cells using Fugene 6 (Roche). Adenovirus bearing LacZ was obtained from Clontech. The viruses were propagated on Ad293 cells and purified using CsCl 2 banding followed by dialysis against 20 mmol/l Tris-buffered saline with 2% glycerol. Titering was performed on Ad293 cells using Adeno-X Rapid Titer kit (Clontech) according to the instructions of the manufacturer.
Western Blotting
Proteins were prepared and separated on SDS-PAGE as described 2 . Immunoblotting was performed using antibodies to eNOS (1:1000 dilution; Abgent), to Flag-tag (1:1000 dilution; Sigma), to Myc-tag (1:1000 dilution; Invitrogen), to eEF1A (1:500 dilution; Santa Cruz), and to α-tubulin (1:5000 dilution; Sigma). Immunodetection was accomplished using a sheep antimouse secondary antibody (1:2000 dilution) or donkey anti-rabbit secondary antibody (1:2000 dilution) and the enhanced chemiluminescence kit (Amersham Corp).
Luciferase Reporter Assay
Fire luciferase cDNA fused with eNOS mRNA 3'-UTR (420nt, 3906 to 4325) was cloned in pcDNA3.0 vector. Bovine endothelial cells (70% confluent) and COS7 cells were transfected with the indicated cDNA constructs using FuGENE 6 transfection reagent. 48 h after transfection, cell lysates were assayed for luciferase activities using the dual Luciferase Assay System (Promega). We used Renilla luciferase as a control for transfection efficiency. Values for firefly luciferase were normalized to Renilla luciferase under the control of the thymidine kinase promoter in the pRLTK vector.
Northern Blotting
Recombinant adenoviruses harboring LacZ (AdLacZ) and human eEF1A1 (AdeEF1A1) were generated by using the AdEasy XL Adenoviral Vector system (Stratagene) according to the manufacturer's instructions. To analyze the effect of eEF1A1on eNOS mRNA stability, HUVECs (70% confluent) were infected with AdLacZ and AdeEF1A1 at MOI of 100 for 48 hours, then 20μg/mL 5,6 -dichloro-1-β-D-ribofuranosylbenzimidazole (DRB, Sigma) was added.
Total RNAs were prepared 0-24 hours thereafter. Equal amounts of total RNA (15 µg) were separated by 1% formaldehyde-agarose gel electrophoresis and the human full-length eNOS cDNA was labeled with the DECAprime II Random Priming DNA Labeling Kit (Ambion).
Conditions for hybridization and washing were performed as described 4, 5 . RNA loading was
